Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Oct 10, 2011; 2(10): 339-343
Published online Oct 10, 2011. doi: 10.5306/wjco.v2.i10.339
Published online Oct 10, 2011. doi: 10.5306/wjco.v2.i10.339
Table 1 Patient characteristics
| Chemotherapy alone (n = 37) | Chemo-immunotherapy (n = 31) | |
| Gender | ||
| Male | 29 | 19 |
| Female | 8 | 12 |
| Age (yr) | 40-84 | 42-82 |
| Median | 68 | 67 |
| Performance status | ||
| 0 | 5 | 5 |
| 1 | 26 | 15 |
| 2 | 3 | 5 |
| 3 | 3 | 6 |
| Pathology | ||
| Intestinal | 13 | 10 |
| Diffuse | 24 | 21 |
| S-1-based chemotherapy | ||
| S-1 alone | 12 | 12 |
| S-1/paclitaxel | 4 | 7 |
| S-1/cisplatin | 18 | 6 |
| PSC | 3 | 6 |
- Citation: Ina K, Furuta R, Kataoka T, Kayukawa S, Yoshida T, Miwa T, Yamamura Y, Takeuchi Y. Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy. World J Clin Oncol 2011; 2(10): 339-343
- URL: https://www.wjgnet.com/2218-4333/full/v2/i10/339.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i10.339